• Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumor-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer.
    • Vysyaraju NR, Paul M, Ch S, Ghosh B, Biswas S.
    • J Drug Target. 2022 Jun 19:1-27. doi: 10.1080/1061186X.2022.2092623. Epub ahead of print.